Prognosticators of survival in differentiated thyroid carcinoma

[Differentiated thyroid carcinoma: survival and prognostic factors].

BACKGROUND AND AIMS Differentiated thyroid carcinoma (DTC) is the most common endocrine tumor. DTC has a good prognosis and survival rates higher than 85%. The aim of our study was to assess our current survival rate and to analyze prognostic factors. PATIENTS AND METHODS A retrospective analysis was conducted of 308 patients with DTC (93.5% with papillary tumors, 78.8% women). Mean age at di...

Evaluation of Treatment of Differentiated Carcinoma of Thyroid.

The treatment of patient with differentiated carcinoma of thyroid consists of three stages, surgery, I 1.1.i ablation and hormone therapy. To avoid the problems mentioned in the article, initially the patient should have thyroid scan, T.1 , T4, thyroglobulin estimation and a chest x-ray, prior to surgery which should be carried out by a competent surgeon, in order that total thyroidectomy can b...

Prognostic Factors in the Survival Rate of Patients with Differentiated Thyroid Cancer

Background: Thyroid cancer is the most prevalent malignancy of the endocrine systemcancers. Thyroid cancer has increased faster thatn any other malignancy in recent years. Tyroid cancer has different histopathologic types, of which the most common is the differentiated type. Different factors can affect the prognosis of the patients. In this study, we investigated different factors that can aff...

Bone marrow radiation dosimetry of high dose 131I treatment in differentiated thyroid carcinoma patients

Background: Radiation absorbed dose to the red bone marrow, a critical organ in the therapy of thyroid carcinoma, is generally kept below 2 Gy for non-myeloablative therapies. The aim of this study was to calculate bone marrow radiation dose by using MIRDOSE3 package program and to optimize the safe limit of activity to be administered to the thyroid cancer patients. Materials and Methods: In t...

[Prognostic factors in differentiated thyroid carcinoma].